SHARE THIS ARTICLE:

Many people know of the “patch” as a way to battle nicotine addiction.

Now, UC Davis is testing a similar technique to deliver a vaccine for COVID-19.

The Patch

Verndari’s VaxiPatch is a single-dose vaccination kit that uses a dermal patch with a metal microneedle array to deliver vaccines.

The  biopharmaceutical company states that “the technology eliminates the need for refrigeration, facilitates high-volume, automated manufacturing of vaccines and can potentially be self-administered on the subject’s arm.”

“The technology eliminates the need for refrigeration, facilitates high-volume, automated manufacturing of vaccines and can potentially be self-administered on the subject’s arm.”Verndari Inc.

Verndari’s chief executive officer, Daniel R. Henderson, says, “Our new approach and previous work enabled us to quickly bring a potential vaccine against COVID-19 to preclinical testing. UC Davis provides a world-class forum for testing, with leading researchers and a full spectrum of supporting capabilities.”

Mouse Biology Program

Pre-clinical testing of the immune response to the vaccine began May 1 at the UC Davis Mouse Biology Program. Researchers there amended an existing protocol for influenza to test a COVID-19 vaccine in rats.

Kristin Grimsrud is a veterinarian and lead scientist at the Mouse Biology Program. She says, “Due to the impressive campus-wide effort to accelerate essential COVID-19 research, we were able to get approval on the amended protocol in less than 72 hours, allowing us to focus on SARS-CoV-2 vaccines.”

Rhesus Macaques

Verndari is also in discussions with the California National Primate Research Center at UC Davis to conduct further testing in rhesus macaques, a powerful animal model for COVID-19.

If the pre-clinical testing meets safety and efficacy goals, Phase 1 human clinical trials could begin.

 

One Response

  1. Richard Pollack

    What is going on with this clearly game changing vaccine approach?

    It is January 8th, 2021 as I write this and I am aware of no public use or even news of this
    elegant technology!

    Roll it out, the world needs it…

    Richard Pollack

    Reply

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

We've got issues, and we're willing to share
(but only if you want them in your inbox).